SCHEMBL7704792

SCHEMBL7704792

CCOC(=O)C1=Cc2cccc(C(=O)NCCN(C)C)c2OCC1

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 3/20 0.39
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
RAD52 P43351 3/20 0.38
SMARCA2 P51531 1/20 0.38
HSD17B10 Q99714 1/20 0.36
AOX1 Q06278 1/20 0.36
CHEK1 O14757 1/20 0.35
CHEK2 O96017 1/20 0.35
USP2 O75604 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7699846 0.83 TSHR (0.46) ALDH1A1KDM4EHTTSMN1; SMN2HSD17B10
SCHEMBL7702968 0.81 TSHR (0.41) ALDH1A1KDM4ESMN1; SMN2HSD17B10L3MBTL1
Hydrochloric Acid SCHEMBL7696598 0.81 RAD52 (0.38) ALDH1A1KDM4EHTTSMN1; SMN2RAD52
Hydrochloric Acid SCHEMBL7696592 0.81 RAD52 (0.39) ALDH1A1KDM4EHTTSMN1; SMN2RAD52
SCHEMBL7702347 0.80 PARP1 (0.50) ALDH1A1SMN1; SMN2HSD17B10L3MBTL1
SCHEMBL7385304 0.77 MAPT (0.39) ALDH1A1KDM4EHTTL3MBTL1TP53
SCHEMBL7696668 0.76 CA12 (0.48) ALDH1A1HSD17B10TP53
SCHEMBL7386364 0.75 CA12 (0.37) ALDH1A1KDM4EHSD17B10L3MBTL1TP53
SCHEMBL7385154 0.75 ALDH1A1 (0.43) ALDH1A1KDM4ESMN1; SMN2HSD17B10L3MBTL1
SCHEMBL7698997 0.75 CYP4F2 (0.41) ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6346527-B1 1-BENZOXEPIN DERIVATIVES USED IN THE PREVENTION OF SODIUM AND HYDROGEN ION EXCHANGE; CARDIOVASCULAR, KIDNEY AND BRAIN DISORDER TREATMENT; ARTERIOSCLEROSIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-02-12 US disclosed